Molecular Design TRIZ Cases

Decentralized identifiers and owner-controlled authorization make chemical product passports more reliable and easier to share across the supply chain.

Decentralized identifiers and segmented battery data improve supply chain traceability while protecting sensitive manufacturing information.

A decentralized chemical product passport structures emission data with controlled access, improving data quality, sharing efficiency, and supplier ownership.

A semantic model and decentralized identifier keep chemical product passports lightweight while preserving secure access to full lifecycle data.

Decentral identifiers link battery component data into a shareable passport, reducing static database errors while preserving supplier ownership.

Automated allocation of supply material attributes enables real-time production control while keeping each product aligned with its target environmental impact.

A digital passport links curable compositions to environmental attributes and decentralized IDs for transparent, secure supply chain tracing.

Digital passports link aqueous polymeric compositions to environmental attributes, improving traceability across complex supply chains.

Maps a product’s physical identifier to a decentralized passport so recyclate and bio-based data can be shared more reliably across the supply chain.

Decentralized identifiers turn static chemical data records into secure product passports that simplify exchange, verification, and ownership control.

Indirect digital access elements let coating material data be shared across supply chains with tighter access control and less exchange complexity.

Differentiable ML links molecule generation, docking, and scoring to explore wider chemical space with lower drug discovery cost.

Differentiable generation, docking, and scoring guide ligand candidates toward binding affinity and synthetic accessibility with lower search cost.

Edit heuristics and mapped molecule specifications speed large catalog searches while improving bioactivity relevance in drug candidate discovery.

A CIM-based docking workflow maps ligand-receptor matching to maximum weight clique search, cutting screening time and false positives.

Integrated GenAI, in-silico, in-vitro, and in-vivo workflows speed novel molecule generation while improving ADMET filtering and lead quality.

Integrates GenAI, docking, and ADMET filtering to generate and optimize target-specific lead molecules faster and more accurately.

Hybrid VAE and evolutionary optimization generates target molecules around user-defined properties while screening similarity, fitness, and toxicity.

A parent-child reinforcement learning policy narrows compound libraries by optimizing binding, selectivity, and ADME before wet lab testing.

Denoising 3D voxel embeddings guides molecule generation toward desired properties while preserving conformations and long-range dependencies.

Filtered transcriptomics and genomics data are biclustered to prioritize GBM treatment targets and drug combinations with higher selectivity.

Voxel-based denoising iteratively refines 3D molecular representations to explore chemical space and generate conformations with desired properties.

An evolutionary search cycle generates, filters, and learns molecular candidates to cut wet-lab cost and speed structure optimization.

A statistical model phases tumor DNA and RNA mutations from short reads to estimate haplotypes and improve neoantigen prediction.

Embedding-based reaction retrieval predicts synthesis recipes from incomplete chemical queries, cutting development time and experimental cost.

An end-to-end ML workflow generates candidate molecules and screens synthesis routes early to cut user bias, delays, and unviable options.

A neural network ranks ligand docking poses to improve conformation prediction accuracy while reducing the cost of physics-based scoring.

Grammar VAE and heuristic manifold traversal improve valid molecule generation while reducing random latent-space exploration time.

Restraint potentials limit artificial atom couplings and improve configurational overlap for more accurate free energy calculations.

Multimodal pocket and peptide features guide unnatural amino acid selection to improve binding specificity, stability, and peptide half-life.

Contrastive learning links pharmacogenomic variants to protein sequences, improving target discovery, drug repurposing, and personalized treatment.

Molecular dynamics predicts antibody viscosity, clearance, and stability to speed selection of mAbs for stable low-viscosity delivery.

AI identifies and regenerates molecular fragments within 3D protein structures to speed drug optimization and cut discovery labor.

Wavelet-based graph decoding preserves multi-frequency signal detail to generate more diverse structured data with faster reconstruction.

Bias-guided ligand traversal across receptor surfaces reveals multiple binding pockets in one simulation, cutting computation and improving target discovery.

Multiple ligand poses are weighted with attention to capture entropic effects and improve compound-polymer bioactivity prediction.

Iterative training with pseudo-matched molecule pairs helps generate molecules with improved binding affinity, specificity, and developability.

Matched molecular pairs train an embedding model to generate molecules with improved binding affinity, specificity, and developability.

Generates improved molecules by encoding linear and 3D structures, helping boost binding affinity, specificity, and developability.

Alignment-based generative training improves 3D protein-ligand structure prediction while reducing data and compute demands through modular models.

A learned encoder-decoder and denoising model generates molecules with improved affinity, specificity, and developability from input structures.

Arranging Cα atoms on a circumference broadens cyclic peptide conformation search and helps find stable structures missed by linear cyclization.

A modular AI engine uses creator, descriptor, and scientist modules to expand drug design spaces while reducing computational complexity.

Flow measures combined with action values balance exploration and reward-seeking when generating biochemical structures, reducing mode collapse and instability.

High-concentration mAb formulations can become too viscous; computational structural models help select candidates with suitable viscosity, clearance, and stability.